Oxidative Stress is an Early Event in Hydrostatic Pressure Induced Retinal Ganglion Cell Damage
Overview
Authors
Affiliations
Purpose: To determine whether oxidative adduct formation or heme oxygenase-1 (HO-1) expression are altered in retinal ganglion cell (RGC) cultures exposed to elevated hydrostatic pressure and in a mouse model of glaucoma.
Methods: Cultured RGC-5 cells were subjected to 0, 30, 60, or 100 mm Hg hydrostatic pressure for 2 hours, and the cells were harvested. Parallel experiments examined the recovery from this stress, the effect of direct 4-hydroxy-2-nonenal (HNE) treatment, and the effect of pretreatment with resveratrol or quercetin. Mice were anesthetized and intraocular pressure was increased to 30, 60, or 100 mm Hg for 1 hour; then the retinas were harvested. HNE adduct formation and HO-1 expression were assessed by immunocytochemistry and immunoblotting.
Results: Increases of HNE-protein adducts (up to 5-fold) and HO-1 expression (up to 2.5 fold) in pressure-treated RGC-5 cells were dose dependent. During recovery experiments, HNE-protein adducts continued to increase for up to 10 hours; in contrast, HO-1 expression decreased immediately. HNE, at a concentration as low as 5 muM, led to neurotoxicity in RGC-5 cells. HNE adducts and HO-1 expression increased in the mouse retina and optic nerve after acute IOP elevation up to 5.5-fold and 2-fold, respectively. Antioxidant treatment reduced the oxidative stress level in pressure-treated RGC-5 cells.
Conclusions: This study demonstrates that oxidative stress is an early event in hydrostatic pressure/IOP-induced neuronal damage. These findings support the view that oxidative damage contributes early to glaucomatous optic neuropathy.
Glaucoma: Current and New Therapeutic Approaches.
Lee H, Tsung T, Tsai Y, Chen Y, Lu D Biomedicines. 2024; 12(9).
PMID: 39335514 PMC: 11429057. DOI: 10.3390/biomedicines12092000.
Retinal Neurodegeneration in an Intraocular Pressure Fluctuation Rat Model.
Han J, Park C, Jung K Int J Mol Sci. 2024; 25(7).
PMID: 38612500 PMC: 11011540. DOI: 10.3390/ijms25073689.
Potential role of polysaccharides in glaucoma management: evidence from preclinical studies.
Lakshmanan Y, Wong F, So K, Chan H Neural Regen Res. 2023; 18(12):2623-2632.
PMID: 37449600 PMC: 10358649. DOI: 10.4103/1673-5374.355977.
m6A Modification-Association with Oxidative Stress and Implications on Eye Diseases.
Ni Y, Zhang H, Chu L, Zhao Y Antioxidants (Basel). 2023; 12(2).
PMID: 36830067 PMC: 9952187. DOI: 10.3390/antiox12020510.
Erythropoietin in Glaucoma: From Mechanism to Therapy.
Lai Y, Lin T, Chen Y, Lu D Int J Mol Sci. 2023; 24(3).
PMID: 36769310 PMC: 9917746. DOI: 10.3390/ijms24032985.